Methylphenidate treatment increases Na+, K+-ATPase activity in the cerebrum of young and adult rats

Journal of Neural Transmission

Volumn 116, Issue 12, 2009, Pages 1681-1687

  Scherer, Emilene B S ^a   Matté, Cristiane ^a   Ferreira, Andréa G K ^a   Gomes, Karin M ^b   Comim, Clarissa M ^b   Mattos, Cristiane ^a   Quevedo, João ^b   Streck, Emilio L ^b   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Hippocampus; Methylphenidate; Na+, K+ ATPase; Prefrontal cortex; Striatum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

AGING; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRUM; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; METHYLPHENIDATE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS;

EID: 70949090178     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0306-x     Document Type: Article

References (54)

1. C Achat-Mendes KL Anderson Y Itzhak 2003 Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood Neuropharmacology 45 106 115 10.1016/S0028-3908(03)00135-7 1:CAS:528:DC%2BD3sXks1alsrY%3D 12814663 (Pubitemid 36695015)
2. W Adriani D Leo D Greco M Rea U di Porzio G Laviola C Perrone-Capano 2006 Methylphenidate administration to adolescent rats determines plastic changes on reward-related behavior and striatal gene expression Neuropsychopharmacology 31 1946 1956 10.1038/sj.npp.1300962 1:CAS:528:DC%2BD28XotFKltLY%3D 16319916 (Pubitemid 44246341)
3. SL Andersen 2005 Stimulants and the developing brain Trends Pharmacol Sci 26 237 243 10.1016/j.tips.2005.03.009 1:CAS:528:DC%2BD2MXjslKhsL4%3D 15860370 (Pubitemid 40603071)
4. AF Arnsten JC Steere RD Hunt 1996 The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder Arch Gen Psychiatry 53 448 455 1:CAS:528:DyaK28Xjt12nu7g%3D 8624188
5. T Banaschewski D Coghill P Santosh A Zuddas P Asherson J Buitelaar M Danckaerts M Döpfner SV Faraone A Rothenberger J Sergeant HC Steinhausen EJ Sonuga-Barke E Taylor 2006 Long-acting medications for the hyperkinetic disorders: a systematic review and European guideline Eur Child Adolesc Psychiatry 15 476 498 10.1007/s00787-006-0549-0 16680409 (Pubitemid 46020533)
6. J Biederman SV Faraone 2005 Attention-deficit hyperactivity disorder Lancet 366 237 248 10.1016/S0140-6736(05)66915-2 16023516 (Pubitemid 40981053)
7. N Bock DJ Quentin G Hüther GH Moll T Banaschewski A Rothenberger 2005 Very early treatment with fluoxetine and reboxetine causing long lasting changes of the serotonin but not the noradrenaline transporter in the frontal cortex of rats World J Biol Psychiatry 6 107 112 10.1080/15622970510029731 16156483 (Pubitemid 40895134)
8. CA Bolanos M Barrot O Berton D Wallace-Black EJ Nestler 2003 Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood Biol Psychiatry 54 1317 1329 10.1016/S0006-3223(03)00570-5 1:CAS:528:DC%2BD3sXpvVWqtrY%3D 14675795 (Pubitemid 37522155)
9. MM Bradford 1976 A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein-die-binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D 942051
10. G Bush EM Valera LJ Seidman 2005 Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions Biol Psychiatry 57 1273 1284 10.1016/j.biopsych.2005.01.034 15949999 (Pubitemid 40798546)
11. H Carageorgiou A Zarros S Tsakiris 2003 Selegiline long-term effects on brain acetylcholinesterase, Na+, K+-ATPase activities, antioxidant status and learning performance of aged rats Pharmacol Res 48 245 251 10.1016/S1043- 6618(03)00149-X 1:CAS:528:DC%2BD3sXltl2gsrw%3D 12860442 (Pubitemid 36818931)
12. WA Carlezon Jr SD Mague SL Andersen 2003 Enduring behavioral effects of early exposure to methylphenidate in rats Biol Psychiatry 54 1330 1337 10.1016/j.biopsych.2003.08.020 1:CAS:528:DC%2BD3sXpvVWqtrc%3D 14675796 (Pubitemid 37522156)
13. FX Castellanos R Tannock 2002 Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes Nat Rev Neurosci 3 617 628 1:CAS:528:DC%2BD38XlslGrt7k%3D 12154363
14. 2+-stimulated ATPase activity Anal Biochem 157 375 380 10.1016/0003-2697(86)90640-8 1:CAS:528:DyaL28XlvVKgtL0%3D 2946250
15. TD Chase RE Brown N Carrey M Wilkinson 2003 Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats Neuroreport 14 769 772 10.1097/00001756-200304150-00022 1:CAS:528: DC%2BD3sXivVCksro%3D 12692480 (Pubitemid 36570939)
16. T Chase N Carrey E Soo M Wilkinson 2007 Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum Neuroscience 144 969 984 10.1016/j.neuroscience.2006.10.035 1:CAS:528:DC%2BD2sXhsFKqtg%3D%3D 17156936 (Pubitemid 46013999)
17. DW Choi 1988 Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage Trends Neurosci 11 465 469 10.1016/0166-2236(88)90200-7 1:CAS:528:DyaL1MXlsVGi 2469166
18. K Deisseroth S Singla H Toda M Monje TD Palmer RC Malenka 2004 Excitation-neurogenesis coupling in adult neural stem/progenitor cells Neuron 42 535 552 10.1016/S0896-6273(04)00266-1 1:CAS:528:DC%2BD2cXkvVyltL4%3D 15157417 (Pubitemid 38639875)
19. WM Dinn NC Robbins CL Harris 2001 Adult attention-deficit/hyperactivity disorder: neuropsychological correlates and clinical presentation Brain Cogn 46 114 121 10.1016/S0278-2626(01)80046-4 1:STN:280:DC%2BD3MvosVeqsA%3D%3D 11527308
20. M Erecinska IA Silver 1994 Ions and energy in mammalian brain Prog Neurobiol 43 37 71 10.1016/0301-0082(94)90015-9 1:CAS:528:DyaK2cXmsFWqs7s%3D 7972852 (Pubitemid 24221854)
21. AO Fagundes GT Rezin F Zanette E Grandi LC Assis F Dal-Pizzol J Quevedo EL Streck 2007 Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats Int J Devl Neuroscience 25 47 51 10.1016/j.ijdevneu.2006.11.001 1:CAS:528:DC%2BD2sXht1Oksb4%3D (Pubitemid 46162062)
22. SV Faraone J Sergeant C Gillberg J Biederman 2003 The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2 104 113 16946911
23. RM Ferris FLM Tang RA Maxwell 1972 A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamine into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta J Pharmacol Exp Ther 181 407 416 1:CAS:528:DyaE38Xks12qurY%3D 5033010
24. GD Gamaro EL Streck C Matté ME Prediger AT Wyse C Dalmaz 2003 Reduction of hippocampal Na+, K+-ATPase activity in rats subjected to an experimental model of depression Neurochem Res 28 1339 1344 10.1023/A: 1024988113978 1:CAS:528:DC%2BD3sXlvVaju78%3D 12938855 (Pubitemid 38113062)
25. MR Gerasimov M Franceschi ND Volkow O Rice WK Schiffer SL Dewey 2000 Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor Synapse 38 432 437 10.1002/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q 1:CAS:528:DC%2BD3cXotV2msLg%3D 11044890 (Pubitemid 30819122)
26. LS Goldman M Genel RJ Bezman PJ Slanetz 1998 Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents JAMA 279 1100 1107 10.1001/jama.279.14.1100 1:STN:280:DyaK1c3gs1KntA%3D%3D 9546570 (Pubitemid 28177819)
27. I Goldstein T Levy D Galili H Ovadia R Yirmiya H Rosen D Lichtstein 2006 Involvement of Na+, K+-ATPase and endogenous digitalis-like compounds in depressive disorders Biol Psychiatry 60 491 499 10.1016/j.biopsych.2005.12.021 1:CAS:528:DC%2BD28XptFCgurY%3D 16712803 (Pubitemid 44292163)
28. N Hattori K Kitagawa T Higashida K Yagyu S Shimohama T Wataya G Perry MA Smith C Inagaki 1998 Cl-ATPase and Na+, K+-ATPase activities in Alzheimer's disease brains Neurosci Lett 254 141 144 10.1016/S0304-3940(98)00654-5 1:CAS:528:DyaK1cXms1Squ7c%3D 10214977 (Pubitemid 28459401)
29. E Heiligenstein LM Conyers AR Berns MA Miller 1998 Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students J Am Coll Health 46 185 188 1:STN:280:DyaK1c7otVWisw%3D%3D 9519582
30. JR Hernandez 1992 Na+, K+-ATPase regulation by neurotransmitters Neurochem Int 20 1 10 10.1016/0197-0186(92)90119-C
31. JR Hernandez 1992 Na+, K+-ATPase regulation by serotonin in normal and kindled rats Brain Res 593 239 244 10.1016/0006-8993(92)91313-4 1:STN:280:DyaK3s%2Fot1Cltg%3D%3D 1333345
32. R Kuczenski DS Segal 1997 Effects of methylphenidate on extracellular dopamine, serotonin and norepinephrine: comparison with amphetamine J Neurochem 68 2032 2037 1:CAS:528:DyaK2sXivVSjsb4%3D 9109529 (Pubitemid 27176139)
33. +-ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia-relationship to hemispheric dominance Int J Neurosci 112 965 982 10.1080/00207450290025978 12448837 (Pubitemid 34989800)
34. KJ Miller FX Castellanos 1998 Attention deficit/hyperactivity disorders Pediatr Rev 19 373 384 1:STN:280:DyaK1M%2Fit1ejtw%3D%3D 9805463
35. GH Moll S Hause E Rüther A Rothenberger G Huether 2001 Early methylphenidate administration to young rats causing a persistent reduction in the density of striatal dopamine transporters J Child Adolesc Psychopharmacol 11 15 24 10.1089/104454601750143366 1:STN:280:DC%2BD3M3jtVGrtg%3D%3D 11322741
36. CD Munhoz I Glezer EM Kawamoto AP Araújo LB Lepscha CS Planeta R DeLucia C Scavone 2003 Changes in sodium, potassium-ATPase induced by repeated fencamfamine: the roles of cyclic AMP-dependent protein kinase and the nitric oxide-cyclic GMP pathway Neuropharmacology 45 1151 1159 10.1016/S0028-3908(03) 00278-8 1:CAS:528:DC%2BD3sXovVWhtrc%3D 14614957 (Pubitemid 37419991)
37. CC Overtoom MN Verbaten C Kemner JL Kenemans H van Engeland JK Buitelaar MW van der Molen J van der Gugten H Westenberg RA Maes HS Koelega 2003 Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder Behav Brain Res 145 7 15 10.1016/S0166-4328(03)00097-4 1:CAS:528:DC%2BD3sXnslSksr0%3D 14529800 (Pubitemid 37188627)
38. G Polanczyk MS de Lima BL Horta J Biederman LA Rohde 2007 The worldwide prevalence of ADHD: a systematic review and metaregression analysis Am J Psychiatry 164 942 948 10.1176/appi.ajp.164.6.942 17541055 (Pubitemid 46972911)
39. TE Robinson B Kolb 2004 Structural plasticity associated with exposure to drugs of abuse Neuropharmacology 47 Suppl 1 33 46 10.1016/j.neuropharm.2004.06. 025 1:CAS:528:DC%2BD2cXotF2hsbk%3D 15464124 (Pubitemid 39298251)
40. Scaini G, Fagundes AO, Rezin GT, Gomes KM, Zugno AI, Quevedo J, Streck EL (2008) Methylphenidate increases creatine kinase activity in the brain of young and adult rats. Life Sci 83:795-780
41. P Shaw WS Sharp M Morrison K Eckstrand DK Greenstein LS Clasen AC Evans JL Rapoport 2009 Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder Am J Psychiatry 166 58 63 10.1176/appi.ajp.2008.08050781 18794206
42. GD Stanwood P Levitt 2004 Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development Curr Opin Pharmacol 4 65 71 10.1016/j.coph.2003.09.003 1:CAS:528:DC%2BD2cXpsVGjug%3D%3D 15018841 (Pubitemid 38145840)
43. E Taylor M Doepfner J Sergeant P Asherson T Banaschewski J Buitelaar D Coghill M Danckaerts A Rothenberger E Sonuga Barke HC Steinhausen A Zuddas 2004 European Clinical Guidelines for Hyperkinetic Disorder-first update Eur Child Adolesc Psychiatry 13 Suppl 1 7 30
44. SS Valvassori BN Frey MR Martins GZ Réus F Schimidtz CG Inácio F Kapczinski J Quevedo 2007 Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats Behav Pharmacol 18 205 212 10.1097/FBP.0b013e328153daf5 1:CAS:528:DC%2BD2sXktFOnt7w%3D 17426484 (Pubitemid 46624343)
45. ND Volkow GJ Wang JS Fowler SJ Gatley J Logan YS Ding R Hitzemann N Pappas 1998 Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 1325 1331 1:STN:280:DyaK1cvjvVWmsA%3D%3D 9766762
46. ND Volkow G Wang JS Fowler YS Ding 2005 Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder Biol Psychiatry 57 1410 1415 10.1016/j.biopsych.2004.11.006 1:CAS:528:DC%2BD2MXltFSrs7o%3D 15950015 (Pubitemid 40798562)
47. AJ Wood M Elphick DG Grahame-Smith 1989 Effect of lithium and of other drugs used in the treatment of manic illness on the cation-transporting properties of Na+, K+-ATPase in mouse brain synaptosomes J Neurochem 52 1042 1049 10.1111/j.1471-4159.1989.tb01845.x 1:CAS:528:DyaL1MXhs1Kju7k%3D 2538559 (Pubitemid 19085924)
48. ATS Wyse EL Streck P Worm M Wajner F Ritter CA Netto 2000 Preconditioning prevents the inhibition of Na+, K+-ATPase activity after brain ischemia Neurochem Res 25 971 975 10.1023/A:1007504525301 1:CAS:528:DC%2BD3cXls1KnsbY%3D (Pubitemid 30636996)
49. AT Wyse EL Streck SV Barros AM Brusque AI Zugno M Wajner 2000 Methylmalonate administration decreases Na+, K+-ATPase activity in cerebral cortex of rats Neuroreport 11 2331 2334 10.1097/00001756-200007140-00052 1:CAS:528:DC%2BD3cXls1OjtbY%3D 10923695
50. Z Xie A Askari 2002 Na+, K+-ATPase as a signal transducer Eur J Biochem 269 2434 2439 10.1046/j.1432-1033.2002.02910.x 1:CAS:528:DC%2BD38XksVWku7Y%3D 12027880 (Pubitemid 34539270)
51. ZJ Yang M Torbey X Li J Bernardy WC Golden LJ Martin RC Koehler 2007 Dopamine receptor modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets J Cereb Blood Flow Metab 27 1339 1351 10.1038/sj.jcbfm.9600440 1:CAS:528:DC%2BD2sXnvFCqsLg%3D 17213860 (Pubitemid 46985351)
52. M Yano H Steiner 2005 Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits Neuroscience 132 855 865 10.1016/j.neuroscience.2004.12.019 1:CAS:528:DC%2BD2MXjtlWqsr0%3D 15837145
53. LM Zanatta FC Nascimento SV Barros GR Silva AI Zugno CA Netto AT Wyse 2001 In vivo and in vitro effect of imipramine and fluoxetine on Na+, K+-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats Braz J Med Biol Res 34 1265 1269 10.1590/S0100-879X2001001000005 1:CAS:528: DC%2BD3MXotlCrt7w%3D 11593300
54. AI Zugno SS Valvassori EBS Scherer C Mattos C Matté CL Ferreira GT Rezin AT Wyse J Quevedo EL Streck 2009 Na+, K+-ATPase activity in an animal model of mania J Neural Transm 116 431 436 10.1007/s00702-009-0198-9 1:CAS:528:DC%2BD1MXks1Sitr4%3D 19255820